DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ: DMAA · FINANCIAL SERVICES · SHELL COMPANIES
$10.53
-0.28% today
Updated 2026-04-30
Market cap
$355.55M
P/E ratio
55.50
P/S ratio
—
EPS (TTM)
$0.19
Dividend yield
—
52W range
$10 – $11
Volume
0.2M
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
0.00%
ROA
-1.46%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2024 | — | $-479.00 | — | — | — |
| 2025 | $0.00 | $5.94M | — | — | — |